[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343503-105":59,"doc-detail-343503-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mad1-upregulation-sensitizes-to-inflammation-mediated-tumor-formation","MAD1 upregulation sensitizes to inflammation-mediated tumor formation","","Mitotic Arrest Deficient 1 (MAD1L1) is an essential mitotic spindle assembly checkpoint component frequently overexpressed in colon cancer and linked to poor disease-free survival. MAD1 upregulation creates tumor-promotion-associated phenotypes, including reduced chromosomal instability and destabilization of the tumor suppressor p53. Using CRISPR/Cas9, the study generated a dox-inducible HA-MAD1 mouse model. A modest MAD1 increase reduced p53, raised mitotic defects, and, after DSS-induced inflammation, produced colon lesions including mucinous adenocarcinoma.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mad1-upregulation-sensitizes-to-inflammation-mediated-tumor-formation/343503/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mad1-upregulation-sensitizes-to-inflammation-mediated-tumor-formation/343503.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does MAD1 upregulation do in the study model?","Question",{"text":112,"@type":113},"MAD1 upregulation decreases p53 expression and increases mitotic defects consistent with chromosomal instability. It also supports tumor-promoting phenotypes in the colon.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was MAD1 overexpression induced in mice?",{"text":117,"@type":113},"Researchers used CRISPR/Cas9 to insert a doxycycline-inducible promoter and HA tag into the endogenous mouse Mad1l1 gene, enabling dox-dependent expression of HA-MAD1 with rtTA.",{"name":119,"@type":110,"acceptedAnswer":120},"What role did inflammation play in tumor development?",{"text":121,"@type":113},"DSS-induced inflammation in the colon caused a high proportion of mice to develop lesions, including adenocarcinoma, whereas control animals showed no lesion formation. The findings indicate MAD1 upregulation promotes colon tumorigenesis in an inflammatory context.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343503,1790649808,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","PLOS GENETICS  \nOPEN ACCESS  \nCitation: Copeland SE, Snow SM, Wan J, Matkowskyj KA, Halberg RB, Weaver BA (2024) MAD1 upregulation sensitizes to inflammationmediated tumor formation. PLoS Genet 20(10):  \ne1011437 . [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pgen.1011437  \nEditor: Ajit P. Joglekar, University of Michigan,  \nUNITED STATES OF AMERICA Received: June 17, 2024  \nAccepted: September 23, 2024  \nPublished: October 7, 2024  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal.pgen.101](https://doi.org/10.1371/journal.pgen.101)1437  \nCopyright: © 2024 Copeland et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are  \nRESEARCH ARTICLE  \nMAD1 upregulation sensitizes to  \ninflammation-mediated tumor formation  \nSarah E. Copeland1, Santina M. Snow2,3,4, Jun Wan5, Kristina A. Matkowskyj6,7, Richard B. Halberg3,4,7, Beth A. Weaver3,7,8 *  \n1 Molecular and Cellular Pharmacology Graduate Training Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 2 Cancer Biology Graduate Training Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 3 Department of Oncology/McArdle Laboratory for Cancer Research, University of Wisconsin–Madison, Madison, Wisconsin, United States of America, 4 Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 5 Physiology Graduate Training Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 6 Department of Pathology and Laboratory Medicine, University of WisconsinMadison, Madison, Wisconsin, United States of America, 7 Carbone Cancer Center, University of WisconsinMadison, Madison, Wisconsin, United States of America, 8 Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America  \n* [baweaver@wisc.edu](baweaver@wisc.edu)  \nAbstract  \nMitotic Arrest Deficient 1 (gene name MAD1L1), an essential component of the mitotic spindle assembly checkpoint, is frequently overexpressed in colon cancer, which correlates with poor disease-free survival. MAD1 upregulation induces two phenotypes associated with tumor promotion in tissue culture cells–low rates of chromosomal instability (CIN) and destabilization of the tumor suppressor p53 . Using CRISPR/Cas9 gene editing, we generated a novel mouse model by inserting a doxycycline (dox)-inducible promoter and HA tag into the endogenous mouse Mad1l1 gene, enabling inducible expression of HA-MAD1 following exposure to dox in the presence of the reverse tet transactivator (rtTA) . A modest 2-fold overexpression of MAD1 in murine colon resulted in decreased p53 expression and increased mitotic defects consistent with CIN. After exposure to the colon-specific inflammatory agent dextran sulfate sodium (DSS), 31% of mice developed colon lesions, including amucinous adenocarcinoma, while none formed in control animals. Lesion incidence was particularly high in male mice, 57% of which developed at least one hyperplastic polyp, adenoma or adenocarcinoma in the colon. Notably, mice expressing HA-MAD1 also developed lesions in tissues in which DSS is not expected to induce inflammation. These findings demonstrate that MAD1 upregulation is sufficient to promote colon tumorigenesis in the context of inflammation in immune-competent mice.  \nAuthor summary  \n","cbCaisMVSa7oJ3Jg","https://ap.wps.com/l/cbCaisMVSa7oJ3Jg","pdf",3315960,"English","# Abstract\n## Background and rationale\n## Methods and mouse model\n## Key results\n## Conclusions","[{\"question\":\"What does MAD1 upregulation do in the study model?\",\"answer\":\"MAD1 upregulation decreases p53 expression and increases mitotic defects consistent with chromosomal instability. It also supports tumor-promoting phenotypes in the colon.\"},{\"question\":\"How was MAD1 overexpression induced in mice?\",\"answer\":\"Researchers used CRISPR/Cas9 to insert a doxycycline-inducible promoter and HA tag into the endogenous mouse Mad1l1 gene, enabling dox-dependent expression of HA-MAD1 with rtTA.\"},{\"question\":\"What role did inflammation play in tumor development?\",\"answer\":\"DSS-induced inflammation in the colon caused a high proportion of mice to develop lesions, including adenocarcinoma, whereas control animals showed no lesion formation. The findings indicate MAD1 upregulation promotes colon tumorigenesis in an inflammatory context.\"}]","MAD1 upregulation sensitizes to inflammation-mediated tumor formation | PDF",1790051327,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/899503756807349e7bbd084b6e8a63bc.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7dc8323b895bbea9dd27082aad4b44a.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8682382573975deae03e11b460bd668e.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26be8a87c1af0f9d8073145e8ee2e79f.webp",980,1268]